Literature DB >> 7387628

Alkylation by 1,2:5,6-dianhydrogalactitol of deoxyribonucleic acid and guanosine.

E Institóris, J Tamás.   

Abstract

DNA was alkylated in neutral solution at 37 degrees C with 1,2:5,6-dianhydrogalactitol and hydrolysed to yield two principal products, identified as 7-galactitylguanine and 1,6-dideoxy-1,6-di(guanin-7-yl)galactitol. The reaction products were separated by chromatography on Sephadex G-10 and Dowex 50 (H+ form). The two compounds were also obtained by reaction between dianhydrogalactitol and guanosine in acetic acid. The products were characterized from their u.v.-spectral data by comparison with those of the 7-alkylguanines and were also identified by mass spectrometry.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7387628      PMCID: PMC1161443          DOI: 10.1042/bj1850659

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  13 in total

1.  Survival and phase sensitivity of HeLa cells treated with dianhydrogalactitol (NSC-132313).

Authors:  I Pályi
Journal:  Cancer Chemother Rep       Date:  1975 May-Jun

2.  Phase II study of dianhydrogalactitol in malignant glioma.

Authors:  P Espana; P H Wiernik; M D Walker
Journal:  Cancer Treat Rep       Date:  1978-08

3.  Gas-liquid chromatographic analysis of trimethylsilyl derivatives of pyrimidine and purine bases and nucleosides.

Authors:  V Miller; V Pacáková; E Smolková
Journal:  J Chromatogr       Date:  1976-04-28

4.  Phase II study of dianhydrogalactitol and ICRF-159 in patients with advanced breast cancer previously exposed to cytotoxic chemotherapy.

Authors:  D L Ahmann; M J O'Connell; H F Bisel; J H Edmonson; R G Hahn; S Frytak
Journal:  Cancer Treat Rep       Date:  1977 Jan-Feb

5.  Platinum-based polychemotherapy versus dianhydrogalactitol in advanced non-small cell lung cancer.

Authors:  R T Eagan; J N Ingle; S Frytak; J Rubin; L K Kvols; D T Carr; D T Coles; J R O'Fallon
Journal:  Cancer Treat Rep       Date:  1977-10

6.  1,2:5,6-Dianhydrogalactitol in advanced breast cancer.

Authors:  B Hoogstraten; R O'Bryan; S Jones
Journal:  Cancer Treat Rep       Date:  1978-05

7.  Isolation and identification of products from alkylation of nucleic acids: ethyl- and isopropyl-purines.

Authors:  P D Lawley; D J Orr; M Jarman
Journal:  Biochem J       Date:  1975-01       Impact factor: 3.857

8.  Methylation of deoxyribonucleic acid in cultured mammalian cells by N-methyl-N'-nitro-N-nitrosoguanidine. The influence of cellular thiol concentrations on the extent of methylation and the 6-oxygen atom of guanine as a site of methylation.

Authors:  P D Lawley; C J Thatcher
Journal:  Biochem J       Date:  1970-02       Impact factor: 3.857

9.  The interaction of dianhydrogalactitol with DNA in cultured Yoshida sarcoma cells.

Authors:  E Institoris; B W Fox
Journal:  Chem Biol Interact       Date:  1978-07       Impact factor: 5.192

10.  Alkylation by propylene oxide of deoxyribonucleic acid, adenine, guanosine and deoxyguanylic acid.

Authors:  P D Lawley; M Jarman
Journal:  Biochem J       Date:  1972-02       Impact factor: 3.857

View more
  6 in total

1.  Benzamide potentiation of the cytotoxicity of bifunctional galactitol [correction of galacticol] in resistant P388 leukemia correlates with inhibition of DNA ligase II.

Authors:  E Institoris; B W Fox; I Pályi
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

2.  Dominance of resistance to the alkylating agent 1,2:5,6-dianhydrogalactitol in P388 mouse lymphoma hybrid cells.

Authors:  I Pályi; J Bence; K Szikla; L Hullán
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 3.  Updates in IDH-Wildtype Glioblastoma.

Authors:  Mary Jane Lim-Fat; James R Perry; Jawad M Melhem; Jay Detsky
Journal:  Neurotherapeutics       Date:  2022-05-31       Impact factor: 6.088

4.  Absence of cross-resistance between two alkylating agents: BCNU vs bifunctional galactitol.

Authors:  E Institóris; K Szikla; L Otvös; F Gál
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

5.  Dominant expression of multidrug resistance in intraspecific murine lymphoma hybrid cells.

Authors:  I Pályi; G Turi; L Hullán; K Szikla; M Bak
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

6.  Dianhydrogalactitol Overcomes Multiple Temozolomide Resistance Mechanisms in Glioblastoma.

Authors:  Miguel Jiménez-Alcázar; Álvaro Curiel-García; Paula Nogales; Javier Perales-Patón; Alberto J Schuhmacher; Marcos Galán-Ganga; Lucía Zhu; Scott W Lowe; Fátima Al-Shahrour; Massimo Squatrito
Journal:  Mol Cancer Ther       Date:  2021-04-12       Impact factor: 6.009

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.